ArticlePDF Available

Effects of Transfer Point Glucan #300 Supplementation on Children exposed to Passive Smoking -Placebo-driven Double-blind Clinical Trials

Authors:
  • Zdravotní ústav se sídlem v Ústí nad Labem Czech republic

Abstract and Figures

Introduction
Content may be subject to copyright.
Annex Publishers | www.annexpublishers.com
Volume 1 | Issue 1
Eects of Transfer Point Glucan #300 Supplementation on Children exposed to
Passive Smoking - Placebo-driven Double-blind Clinical Trials
Richter Josef1, Král Vlastimil1, Svozil Vladimir2, Rajnohova Dobiasova Lucie1, Pohorska Jitka1, Stiborova
Ivana1, Vetvicka Vaclav*3
1Zdravotní ústav se sídlem v Ústí nad Labem, Czech Republic
2Sanatorium Edel, Zlaté Hory, Czech Republic
3University of Louisville, Department of Pathology, Louisville, KY, USA
*Corresponding author: Dr. Vetvicka Vaclav, University of Louisville, Department of Pathology, 511 S.
Floyd, Louisville, KY 40202, USA, E-mail: vaclav.vetvicka@louisville.edu
Research Article Open Access
Volume 1 | Issue 1
Journal of Nutrition Health
Abstract
Introduction
Lately, there has been increasing interest in the relationship between environmental contaminants and health of the population.
Children are the most sensitive to environmental contaminants, mostly due to their higher ventilation, immature immune system
and, compared to adult population, longer stay outside [1]. e eect of environmental pollution inuences a higher sickness rate,
a higher chance of respiratory infections and the rate of allergic diseases including asthma [1]. It is important to note that con-
taminations of the inside environment, mostly tobacco smoke, are as eective as pollution outside. e eects of passive smoking
on development of allergies demonstrated by elevated levels of IgE at risk children population are well established. e highest
level of eects of pollution is manifested in children suering from asthma and in children with chronic respiratory problems
[2]. Asthmatic children exposed to tobacco smoke have higher IgE levels, which are caused not only by genetic disposition, but
also indirectly by higher penetration of allergens through damaged mucosa [2]. Clinical manifestations of allergies, asthma and
chronic respiratory diseases are further inuence by living close to roads with high trac. Nitrogen oxides and most of all nano-
particles present in exhaust fumes increase clinical problems based on suppression of immunity [3-5]. Monitoring of the eects
of these stress factors by evaluation of levels of salivary cortisol oers important information about the relationship between envi-
ronmental stress and actual the health quality of children. Both aerial and food allergens can serve as triggers of stress reaction [6].
e intensity of stress reaction is inuenced by individual sensitivity. Allergic population, asthmatics and people with respiratory
allergy have higher levels of salivary cortisol [6,7]. Increased response of the hypothalamo-hypophyse-adrenal axis to stress was
found to be higher in healthy individuals with a predisposition to allergic diseases [7]. We believe that β-glucans used in our study
might inuence the individual’s response to the stress [8,9].
In this study, we focused on the eect of β-glucan supplementation of children with chronic respiratory problems. We measured the
levels of cortisol, salivary IgE and cotinine in 56 children and evaluated the eect of 30 day supplementation with 100 mg/day oral
dose of yeast-derived β-glucan. Our results showed strong decrease of cotinine and cortisol levels in saliva of β-glucan-supplemented
children. e increase of total salivary IgE levels in both groups was not statistically signicant. e positive eects of complex cura-
tive treatment using β-glucan were accompanied by increased physical endurance and by signicant reduction of negative clinical
problems of aected children.
Citation: Richter Josef, Král Vlastimil, Svozil Vladimir, Rajnohova Dobiasova Lucie, Pohorska Jitka, et al.
(2014) Eects of Transfer Point Glucan #300 Supplementation on Children exposed to Passive Smoking -
Placebo-driven Double-blind Clinical Trials. J Nutr Health 1: 105
Keywords: Glucan; Children; Saliva; IgE; Cotinine; Smoking
β-Glucan’s role as a biologically active immunomodulator has been well documented for over 50 years. Interest in its immu-
nomodulatory eects was initially raised by experiments that showed that a crude yeast extract stimulated macrophages via acti-
vation of complement system [10]. Subsequent work identied the immunoactive component as β-1,3-D-glucan [11]. Numerous
publications (currently more than 5,000 studies) have shown that β-glucans, either soluble or particulate, exhibit anti-bacterial,
anti-cancerous, anti-infectious and anti-stress activities (for review see [12-14]).
Received Date: April 1, 2014 Accepted Date: May 16, 2014 Published Date: May 20, 2014
Annex Publishers | www.annexpublishers.com
Volume 1 | Issue 1
Journal of Nutrition Health
2
In order to better evaluate the complex eects of sanatorium conditions of glucan-supplemented children, we added not only
evaluation of some immunological parameters, but also clinical evaluation and functional Six Minute Walk Test (6 MWT), which
is valuable test for measuring reaction to physical endurance [15]. Our present study reports signicant benecial eects of addi-
tion of glucan.
e same protocol that was previously described [16-18] was used throughout this study. Briey, a randomized, double-blind, pla-
cebo-controlled trial compared β-glucan #300 and placebo in children. Sixty children from the Sanatorium for respiratory diseases
EDEL Czech Republic were enrolled in the 4-week trial and 56 were used. e reason for exclusion was leaving the Sanatorium
prematurely for non-medical reasons. e clinical trial was conducted at the Sanatorium EDEL (Zlate Hory, Czech Republic) and
the study was approved by the Ethics committees of the Public Health Institute and Sanatorium EDEL. is study was performed
in agreement with Helsinki declaration (revised version 2000.09.01) and was in full compliance with the rules of for clinical testing
in the Czech Republic. Parental consent was given in all cases.
Subjects were randomly assigned to groups which were blinded to intervention. During the intervention period, the subjects
consumed 100 mg/d of β-glucan or placebo. Both glucan and placebo capsules looked identical. Subjects were routinely evaluated
by the medical sta. Four patients were excluded from the study, due to either an abbreviated stay in the sanatorium or due to a
shortened stay based on the parent’s request.
e quality of environment was measured at the place of residence and at the Sanatorium EDEL by testing levels of sulphur diox-
ide, nitrogen oxide and particles of sizes PM 2.5 and PM 10. Overall meteorological conditions were based on countrywide net
of atmosphere monitoring stations. Levels of pollen particles were also measured both at the place of residence and Sanatorium
EDEL using a Burkard 7 Day Recording Volumetric Spore Sampler (Burkard Agronomics TGB). Pollen monitoring stations are
parts of the Czech Pollen Information Service, member of the European Pollen Information Service (www.polleninfo.org).
Glucan
Yeast-derived insoluble Glucan #300 (>85% dry w/w basis) was purchased from Transfer Point (Columbia, SC, USA). is glucan
contains 96% carbohydrates and 2.1% proteins. Neutral sugar analysis conrmed 91.3% glucose and 8% mannose.
Quality of environment
Epidemiological data were obtained using two forms – rst one lled by parents, the second one by medical sta of the Sanato-
rium EDEL. In all tested individuals, we collected samples of saliva using a commercial Salivette device (Sarstead, Orsay, France).
Aer two minutes of chewing, the cotton swab was added into a sterile container and centrifuged at 1,000 g for 15 minutes and
stored at -20 oC. We used identical times (between 8 and 9 AM) for sampling, so the possible inuence of circadian rhythms could
be eliminated. Levels of cotinine were measured in saliva by an ELISA kit Salimetrix according to the manufacturer’s instruction
(Salimetrix Europe, Newmarket, UK). With the suggested laboratory temperature of 20-23 oC, the sensitivity of the method is
around 0.15 ng/ml. In all subject, these measurements were done at day 0 and at day 30. Cortisol levels were also measured by
Salimetrix kits (Salimetrix High Sensitivity Salivary Assay Kit) with sensitivity of 0.0007 μg/L. Total IgE levels were determined
by high anity uoroenzymatic assay using an ImmunoCAP 250 analyzator and kits and equipment Phadia (Uppsala, Sweden)
with sensitivity of 0.005 IU/ml. All participants absolved at the beginning and at the end 6MWT based on suggested development,
including evaluation of additional parameters such frequency before and aer physical stress, oxygen saturation, interruption of
stress due to the tiredness. ese tests were done 2 hrs aer the meal.
Materials and Methods
Protocol
Tests
Statistical analysis
Statistical signicance was evaluated by a pair t-test using a GraphPad Prism 5.04 soware (GraphPad Soware, USA). An aver-
age and standard deviation was evaluated aer determination of composition of standard values (D’Agostino, Pearson). In case of
non-standard composition, we converted the values into logarithms.
Results
e glucan-consuming group consisted of 29 children (age 7 – 14 years, mean 9.7; the placebo consuming group used 27 children
(age 6 – 16, mean 10.1). Both groups were the same with respect to birth weight or sex (Table 1). e glucan group had 72% breast-
fed children; the placebo group had 89%. e dierences in duration of breast feeding were statistically not signicant and no dif
Annex Publishers | www.annexpublishers.com
Volume 1 | Issue 1
Journal of Nutrition Health
3
ferences were found in average weight or percentage of children with their BMI higher than 95% or lower than 5% suggested by
CDC. e glucan-supplemented group had slightly elevated allergenic stress by domestic animals allergens. Exposure to passive
smoking was indentical in both groups. e percentage of children with 50 m distance between homes and roads with high trac
frequency were 58.5% in glucan group and 64% in placebo group. e number of children with asthma was same in both groups;
chronical obstruction of lungs was higher in placebo group. Clinical ndings of allergy were 37.9% in the glucan group, 14,8% in
placebo group. 6MWT values at the beginning of our study are given in Table 1.
e environmental characteristics of our patients did not substantially dier from data published previously [16-18]. e levels of
sulphur oxide were almost 4x higher at the place of residence than in Sanatorium EDEL, the same is true about levels of nitrogen
oxide. e highest dierences were found in levels of particles, where PM 10 levels at residence reached 50 mg/m3, whereas levels
at the Sanatorium are 13.0 mg/m3. Almost identical dierences were found in case of PM 2.5 (average 40 mg/m3 vs. 10 mg/m3). e
dierence primarily all due to the distance from frequented routes, which at the Sanatorium is over 1 500 m, whereas more than
50% of evaluated children lives less than 50 m from a road with high frequency of automobile trac (Table 1). Another stress on
the respiratory tract is caused by additional contaminants of environment, particularly pollen. e dierences between home and
Sanatorium levels of pollen were again signicant. Table 2 summarized individual contaminants present during March and April.
Cumulation of negative factors aecting respiratory tract is further increased by high exposure of children to passive smoke, which
is common in almost 50% of children. Relatively high indoor pollution is caused by pets, which is in the asthmatic group higher
than 50% (Table 1). As the types of residences are almost identical in both groups (mostly panel housing), both groups had the
same risk on indoor contamination. Levels of salivary cotinine, which is an indicator of exposure to passive smoking, are shown
in Figure 1. Levels found in the glucan group at the beginning (0.85 ng/ml ± 0.26) and at the end of the study (0.235 ng/ml ± 0.07)
are signicantly dierent from the control group (0.436 ng/ml ± 0.22; 0.28 ng/ml ± 0.22, resp.). e cotinine levels decreased aer
30 days of stay at the Sanatorium in both groups, but the glucan-supplemented group showed a much higher rate of decrease.
e possible eects of diet can be negligible, as both groups were getting identical food during the whole stay. e total levels of
cotinine at the glucan group were strongly inuenced by extremely high levels found in three children. ese levels were most
probably caused by demonstrated multiple exposure to tobacco smoke with three strong smokers in the family.
Figure 2 summarizes the ndings of the cortisol levels. At the beginning of our study, the levels found in both groups were statis-
tically identical (0.45 and 0.42 μg/ml). A decrease in cortisol levels aer the 30 day stay was found in both groups, however, the
decrease was signicant only in glucan group.
Total levels of salivary IgE reached 0.30 ± 0.39 IU/ml in glucan group, in placebo group it was 0.21 ± 0.20 IU/ml. In both groups
we observed an increase in salivary IgE levels, but these changes were not statistically signicant (Figure 3). Detailed study showed
that this increase was most probably caused by seasonal exposure to pollen particles. Evaluation of the 6MWT test demonstrated
an increase of physical capacity from 430 to 445 m (p <0.07) in glucan group, but no changes in the placebo group (Table 1).
G1
G2
P1
P2
G1
G2
P1
P2
Figure 1: B Eects of 4-week oral administration of glucan (100 mg/day) on cotinine levels in saliva. GL 1 represents glucan group at day 1; GL 2
at day 30. C1 represents control (placebo) group at day 1, C 2 at day 30. Data show statisticall signicance between groups.
Cotinine saliva
1.5
1.0
0.5
0.0
ng/ml
Journal of Nutrition Health
4
Annex Publishers | www.annexpublishers.com
Volume 1 | Issue 1
G1
G2
P1
P2
G1
G2
P1
P2
Figure 2: Eects of 4-week oral administration of glucan (100 mg/day) on cortisol levels in saliva. GL 1 represents glucan group at day 1; GL 2 at
day 30. C1 represents control (placebo) group at day 1, C 2 at day 30. Data show statisticall signicance between groups.
Cortisol saliva
0.6
0.4
0.2
0.0
μg/l
G1
G2
P1
P2
G1
G2
P1
P2
Figure 3: B Eects of 4-week oral administration of glucan (100 mg/day) on IgE levels in saliva. GL 1 represents glucan group at day 1; GL 2 at ay
30. C1 represents control (placebo) group at day 1, C 2 at day 30. Data show statisticall signicance between groups.
lgE
1.5
0.3
0.2
0.0
IU/ml
0.8
0.1
0.4
5
Journal of Nutrition Health
Annex Publishers | www.annexpublishers.com
Volume 1 | Issue 1
Table 1: Basic information on tested groups of children
Zlaté HoryBohumínPlant species
17468249AlderAlnus
1710BirchBetula
03BornbeamCarpinus
4911413HaselCorylus
1141306PoplarPopulus
2991184YewTaxus
95243willowSalix
Table 2: e number of pollen grains (1m3 ) in residence children (Bohumín – Moravia) and Sanatorium EDEL
(Zlaté Hory) (March and April 2011)
Placebo groupGlucan group
n= 27n=29Child characteristics
6 - 167 - 14Age (min-max)
10,1 (2,7)9,7 (2,0)Age Mean (SD)
15 (55,6)16 (55,2)Male sex (%)
12 (44,4)13 (44,8)Female sex (%)
3182,73404,6Birth weight (grams)
88,972,4Breastfed (%)
9,777,38Breastfed Month Mean
18,2 (4,4)18,3 (3,5)BMI (SD)
5 (18,5)% 4 (13,8)BMI – for – age percentils >95%
4 (14,8)% 2(6,9)BMI – for – age percentils <5%
8 (29,6)15 (51,7)Pet keeping (%)
12 (44,4)15(51,7)Passive smoking (%)
16 (64)17 (58,6)Living within 50 m of a main street N(%)
9 (36)8 (27,6)Living within 500 m of a main street N(%)
0 (0)4 (4)Living within more m of a main street N(%)
4 (14,8)11 (37,9)Allergy (%)
14 (51,9)16 (55,2)Asthma (%)
9 (33,3)2 (6,9)
COPD (chronic obstructive pulmon. disease )
%
440 (85)430 (38)6 Minute Walk Test I. (SD)
435 (75)445 (57)6 Minute Walk Test II. (SD)
Values are absolute/values (percentages)or means (SD)
Discussion
Currently there is little doubt about the fact that contamination of environment strongly aects the health problems of the whole
population, and children in particular [1]. e overall quality of environment has strong eects on development of immune sys-
tem and on some diseases aecting both mental and physical development [1,3]. Environmental stress is reected in respiratory
tract diseases, development of allergies, increase in occurrence of asthma bronchiale and other health problems [19]. e increase
in prevalence of asthma bronchiale in highly polluted region of the Czech Republic in last decade (2002-2012) achieved more
than 10% and represents a heavy economical strain for the health industry. e only possible way for improvement of the current
state is signicant reduction of all aspects adding to the contamination of the environment. An actual solution can be short term
limination of exposure to environmental contaminants caused by the locality [19]. e eects of this solution were demonstrated
during the Olympic games in Atlanta, were the reduction in automobile trac caused an decrease in overall sickness. e World
Health Organization describes trac-based contaminants as primary causes leading to the developments of allergic diseases. e
Journal of Nutrition Health
6
Annex Publishers | www.annexpublishers.com
Volume 1 | Issue 1
authors conclude that the distance of the residence to the frequented road represents signicant risk factor [5], where living up
to 20 m from heavy frequented street increased the risk of respiratory problems up to 15 percent [3]. In might be important to
note that these ndings will dier among dierent countries, which can be explained not only by dierent age and general state
of the vehicles, but also by prevalent type of engine. An increase of environmental pollution in the Czech Republic is inuenced
not only by high percentage of diesel engines, but also by an average age of cars, which is greater than 10 years. Taken together, we
consider it necessary to monitor quantity and development of pulmonary functions that are heavily inuenced by distance from
trac. Gauderman and his group found signicant changes of pulmonary functions in individuals living closer than 500 meters
from roads compared to people living further than 1 000 meters [4]. In addition, these damages can oen last an entire lifetime. In
our conditions, children oen spent signicant periods of time outdoors; therefore, it is necessary to also calculate the localization
of the school. Among children tested in our report, the distance between the school and busy street was more than 100 meters.
Exposure to passive smoke represents an important health stress aecting the development and quality of the immune system.
Evaluation of the levels of salivary cotinine represents a non-invasive and highly precise indicator of exposure to tobacco smoke.
By measuring the levels of salivary cotinine we can determine the level of exposure and monitor the end of the exposure [20]. e
total levels of cotinine are aected by the combination of exposure and the size of the interior, as well as the relationship between
the smoker and the passive smoker. e highest levels of cotinine can be found in children exposed to the smoke by mother,
whereas the exposure by father leads to the lower levels (probably by forcing the father to smoke outside by non-smoking mother).
e relationship between the cotinine levels and tobacco smoke from both smoking parents is clear and our results are in agree-
ment with results obtained in children from countries such as the United Kingdom, Wales or Sweden [20]. Approximately 75% of
nicotine is converted to cotinine, most of all by cytochrome P450 2A6 [21]. e half-life of cotinine is 16 hours, its levels are stable
throughout the day and the correlation between the ndings in saliva and blood is extremely high. Metabolism of cotinine can be
inuenced by genetic factors, race, sex, and is usually higher in children exposed to passive smoke than in similarly stressed adults
[21]. Higher levels were found in children with asthma bronchiale [21], which our study conrmed. In addition, we pointed out
the eects of environmental contaminants on increase of cotinine levels. In these cases the cotinine levels are higher than the 3
ng/ml cut-o point (NHANES 1999-2004) distinguishing between passive and active smoking [21]. Information of the eects of
passive smoking on childrens health, particularly on their pulmonary system, is in families with aected children oen overlooked
and signicant public education is necessary. Based on the forms utilized in our study, only 30% of the population has any knowl-
edge about the possible eects of passive smoking on induction of asthmatic or allergic diseases. In addition, the full knowledge of
these interactions is not totally understood even in the professional population. A 1/2 imbalance induced by smoking is not
studied in detail, similarly we do not have enough information about T regulation system in passive smokers.
All this oers one of possible ways as to how to inuence health status of passive smokers. It is well known that β-glucans are
strong immunomodulators with positive eects on immunocompetent cells [22]. An optimal application of β-glucan in individu-
als with heavy physical stress reduced respiratory illnesses, increased phagocytic and NK cell activity [22]. Several experiments
demonstrated that glucan treatment aer stress resulted in the decrease of lactate levels, lower activity of creatinine kinase as well
as additional markers demonstrating stronger endurance during higher stress [23]. Eects of β-glucans on activation of mac-
rophages and neutrophils together with their stimulation of phagocytosis, cytotoxicity and antimicrobial activity via activation
of specic receptors (such as CR3, Dectin-1, lactosyl or TLR2-6) are well established (for review see [24]) and can be utilized in
suppression of stress of our group of children. e reasons why we used a relatively short supplementation are twofold – rst, we
wanted to evaluate the hypothesis that glucan can help even aer short interval, and second the 30 days corresponded to the length
of stay in the Sanatorium.
Dynamics of changes in salivary IgE is dierent based on exposure to passive smoking. Higher original levels were found in chil-
dren exposed to smoking, which corresponds to the previous ndings [2]. When re-evaluated aer the 30 day stay at the Sanatori-
um, we found a small insignicant increase, which was most probably caused by seasonal allergens. is exposure was, compared
to residence, signicantly smaller, due to the low allergen exposure from lawn surrounding the whole Sanatorium campus.
It is necessary to understand that children evaluated in our study are under the inuence of chronic stress of complex etiology
(environment, passive smoking, social and economic inuences) [6]. Taking out from long term stress resulted in pronounced
decrease of cortisol levels, which was most pronounced in glucan-supplemented group. Measuring cortisol during morning hours
had no inuence on levels of salivary cotinine, known for increased levels during the day. It is known that allergic patients react
to stress by increase of cortisol levels [6]. e positive eects of glucan on several types of stress have been already described [8].
Later, the positive eects of glucans on respiratory symptoms in individuals with mood stress [9]. Based on our data, we conclude
that immunostimulatory eects of β-glucan resulted in improvements of medical parameters during and aer the medical stay at
the Sanatorium [16,17,25,26].
Positive eects of complex curative treatment using β-glucan are accompanied by increased physical endurance and by signicant
reduction of negative clinical problems of aected children [27]. ese nding are supported by improvements in 6MWT, where
the data in the glucan-treated group corresponds with the normal child population of the same age group [15].
7
Journal of Nutrition Health
e positive eects of complex curative treatment using β-glucan were accompanied by increased physical endurance and by sig-
nicant reduction of negative clinical problems of aected children. Based on these data, we conclude that natural immunomodu-
lator β-glucan signicantly improves the overall health of children with chronic respiratory problems caused by environmental
stress and/or passive smoking.
Acknowledgement
is study was supported by the Technology Agency of the Czech Republic TACR TA 0202094.
References
1. Buka I, Koranteng S, Osormio-Vargas A (2006) e eects of air pollution on the health of children. Paediatr Child Health 11: 513–6.
2. Oryszczyn MP, Annesi-Maesano I, Charpin D, Paty E, Maccario J, et al. (2000) Relationships of active and passive smoking to total IgE in adults of the epide-
miological study of the genetics and environment of asthma, bronchial hyperresponsiveness, and atopy (EGEA). Am J Respir Crit Care Med 161: 1241–6.
3. Bayer-Oglesby L, Schindler Ch, Arx ME, Braun-Fahrlander C, Keidel D, et al. (2006) Living near main streets and respiratory symptoms in adults. Am J Epi-
demiol 164: 1190–8.
4. Gauderman WJ, Vora H, McConnell R, Berhane K, Gillard F, et al. (2007) Eect of exposure to trac on lung development from 10 to 18 years of age: a cohort
study. Lancet 369: 571-7.
5. Morgenstern A, Zutavern A, Cyrys J, Brockow I, Koletzko S, et al. (2008) Atopic diseases, allergic sensitization, and exposure to trac-related air pollution in
children. Am J Respir Crit Care Med 177: 1331–7.
6. Mizawa M, Yamaguchi M, Ueda Ch, Makino T, Shimizu T (2013) Stress evaluation in adult patients with atopic dermatitis using salivary cortisol. BioMed Res
Int 2013: 138027.
7. Stenius F, Borres M, Bottai M, Lilja G, Lindbladt F, et al (2011) Salivary cortisol levels and allergy in children: e ALADDIN birth cohort. J Allergy Clin Im-
munol 128: 1335–9.
Annex Publishers | www.annexpublishers.com
Volume 1 | Issue 1
8. Vetvicka V, Vancikova Z (2010) Anti-stress action of several orally-given β-glucans. Biomed Pap 154: 235–8.
9. Talbott SM, Talbott JA (2012) Baker´s yeast beta-glucan supplement reduces upper respiratory symptoms and improves mood state in stressed women. J Am
Coll Nutr 31: 295-300.
10. Benacerraf B, Sebestyen MM (1957) Eect of bacterial endotoxin on the reticuloendothelial system. Fed Proc 16: 860-7.
11. Rigi SJ, Di Luzio NR (1961) Identication of a reticuloendothelial stimulating agent in zymosan. Am J Physiol 200: 297-300.
12. Novak M, Vetvicka V (2008) β-Glucans, history, and the present: Immunomodulatory aspects and mechanisms of action. J Immunotoxicol 5: 47-57.
13. Novak M, Vetvicka V (2009) β-Glucans as biological response modiers. Immune Dis Drug Targets 9: 67-75.
14. Větvicka V (2011) Glucan-immunostimulant, adjuvant, potential drug. World J Clin Oncol 2: 115 – 9.
15. Li AM, Yin J, Au JT, So HK, Tang T, et al. (2007) Standard reference for the Six-Minute-Walk Test in healthy children aged 7 to 16 years. Am J Respir Crit Care
Med 176: 174–80.
16. Vetvicka V, Richter J, Svozil V, Rajnohova Dobiášova L, Kral V (2013) Placebo–driven clinical trials of Transfer Point glucan #300 in children with chronic
respiratory problems: Antibody production. Am J Immunol 9: 43-7.
17. Vetvicka V, Richter J, Svozil V, Rajnohova Dobiášova L, Kral V (2013) Placebo –driven clinical trials of yeast-derived β-(1,3) glucan in children with chronic
respiratory problems. Ann Transl Med 26: 1–5.
18. Vetvicka V, Richter J, Svozil V, Rajnohova Dobiášova L, Kral (2013) Placebo – driven clinical trials of Transfer Point Glucan #300 in children with chronic
respiratory problems: III. Clinical ndings. Am J Immunol 9: 88–93.
19. Renzetti G, Silvestre G, D´Amario C, Bottini E, et al. (2009) Less air pollution leads to rapid reduction of airway inammation and improved airway function
in asthmatic children. Pediatrics 123: 1051–1153.
20. Abidin EZ, Semple S, Omar A, Rahman HA, Turner SW, et al. (2011) A survey of schoolchildren´s exposure to secondhand smoke in Malaysia. BMC Public
Health 11: 634–45.
22. Bergendiova K, Tibenska E, Majtan J (2011) Pleuran (β-glucan from Pleurotus ostreatus): Supplementation, cellular immune response and respiratory tract
infections in athletes. Eur J Appl Physiol 111: 2033–40.
23. Xu C, Lo IM, Cui SW, Hu X, Fan M (2013) Eects of oat β-glucan on endurance exercise and its anti-fatigue properties in trained rats. Carbohydr Pol 92:
1159–65.
21. Avila-Tang E, Al-Delaimy WK, Ashley DL, Benowitz N, et al. (2013) Assessing secondhand smoke using biological markers. Tobacco Control 22: 164–71.
Conclusions
24. Vetvicka V (2013) β-Glucans as Natural Biological Response Modiers. Nova Science Publishers, New York.
25. Richter J, Svozil V, Král V, Rajnohova Dobiášova L, Stiborova I, et al. (2014) Clinical trials of yeast-derived β-(1,3) glucan in children: eects on innate im-
munity. Ann Transl Med 2: 1 – 6.
26. Vetvicka V, Vančíková Z (2013) 1,3-glukan a alergie. Alergie 4: 6 – 8.
27. Nieman DC, Henson DA, McMahon M, Wrieden JL, Davis JM, et al. (2008) β-Glucan, immune function, and upper respiratory tract infections in athletes.
Med Sci Sport Exercise 40: 1463-71.
... Respiratory tract infections represent the most common cause of sickness in the child population of developing countries (1). In the Czech Republic, the highest prevalence of these health problems occurs in industrial parts of Northern Bohemia and Northern Moravia (2)(3)(4). These are areas of extreme contaminations of the environment, mostly due to the presence of coal mines, heavy chemical industry and power stations using low quality coal. ...
... Ever increasing numbers of respiratory problems, allergies and asthma led us to the studies focusing on a search for possible solutions. Among possible solutions are for children from the most polluted regions to have regular stays in environmentally clear areas, with optimal nutrition, higher physical activity and stimulation of mucosal immunity using specific immunomodulators, particularly β-glucan (2)(3)(4)(5)(6). ...
... Materials from the American Society of Pulmonary Physicians and from the Czech Society of Pneumology Physicians led to subsequent studies evaluating effects of both technical conditions (such as size and length of the track) and personal conditions (such as age, sex, weight or race of the tested individual) (13)(14)(15). More and more studies are trying to prepare standards for the 6WMT in a healthy population in relation to age, sex and other parameters (3,(16)(17)(18)(19). These facts led us to try to evaluate the physical endurance of children during their stay at the Sanatorium EDEL, Zlate Hory, Czech Republic. ...
Article
Full-text available
The role of β-glucan in children with respiratory problems is getting more and more attention. In this report we focused on the effects of 30 days oral supplementation with β-glucan on physical activity and immune status of children with respiratory problems. We measured the level of sIgA, eNO and physical activity [using a 6-minute walking test (6MWT)] in 77 children and evaluated the effect of 100 mg/day oral dose. We found a significant difference between males and females in physical endurance. In the glucan group, the positive effects of glucan were significant in both age groups. In the glucan group, we found significant decrease of eNO levels and stabilization of the sIgA levels. Short-term oral application of natural immunomodulator β-glucan stimulated physical endurance in children with respiratory problems and, via stabilization of the sIgA levels, helps their mucosal immunity.
... Further, a short-term food supplementation with glucan also reduced the levels of salivary albumin and calprotectin ( Figure 6). In addition, the same glucan treatment significantly improved the overall health status and physical conditions of children exposed to passive smoking [68,69]. These studies allowed us to conclude that glucan supplementation is a highly promising and inexpensive method of treatment for chronic respiratory problems in children [70]. ...
... In a rat experimental model, glucan reduced total cholesterol by 32% triglyceride by 64%, and malondialdehyde levels by 45% [90]. Moreover, in a study carried out by the current authors, yeast-derived glucan #300 markedly lowered total cholesterol levels in mice with experimentally-induced hypercholesterolemia [69]. In addition, supplementation with three other glucans, Krestin, ImmunoFiber, and Now glucan, induced similar, albeit less significant effects [48]. ...
... Further, a short-term food supplementation with glucan also reduced the levels of salivary albumin and calprotectin ( Figure 6). In addition, the same glucan treatment significantly improved the overall health status and physical conditions of children exposed to passive smoking [68,69]. These studies allowed us to conclude that glucan supplementation is a highly promising and inexpensive method of treatment for chronic respiratory problems in children [70]. ...
... In a rat experimental model, glucan reduced total cholesterol by 32% triglyceride by 64%, and malondialdehyde levels by 45% [90]. Moreover, in a study carried out by the current authors, yeast-derived glucan #300 markedly lowered total cholesterol levels in mice with experimentally-induced hypercholesterolemia [69]. In addition, supplementation with three other glucans, Krestin, ImmunoFiber, and Now glucan, induced similar, albeit less significant effects [48]. ...
Article
Full-text available
Glucans are part of a group of biologically active natural molecules and are steadily gaining strong attention not only as an important food supplement, but also as an immunostimulant and potential drug. This paper represents an up-to-date review of glucans (β-1,3-glucans) and their role in various immune reactions and the treatment of cancer. With more than 80 clinical trials evaluating their biological effects, the question is not if glucans will move from food supplement to widely accepted drug, but how soon.
... Another group, consisting of 6 trials, reported the same source of funding e a project of Czech Agency for Technology no. 02020944, and they appear very similar in terms of included participants, and likely drawn from the same group of participants [15,16,19,20,22,34]. Two of those trials [19,22] had the same sample size: 56 participants, with 27 in one arm, and 29 in the second arm. ...
... Another group, consisting of 6 trials, reported the same source of funding e a project of Czech Agency for Technology no. 02020944, and they appear very similar in terms of included participants, and likely drawn from the same group of participants [15,16,19,20,22,34]. Two of those trials [19,22] had the same sample size: 56 participants, with 27 in one arm, and 29 in the second arm. Three trials from this group [15,16,34] had 40 participants: 21 in one arm, 19 in the second arm. ...
Article
Background & aims: Beta-glucans are advertised as biologically active compounds, with various health claims. We aimed to summarize results about efficacy and safety of commercial oral and inhalation beta-glucan products on human health from randomized controlled trials (RCTs). Methods: We conducted systematic review of RCTs. We searched MEDLINE, CENTRAL and ClinicalTrials.gov. Any commercial product, any types of participants and any health-related outcomes were eligible. Two authors independently screened studies and extracted data. Cochrane risk of bias tool was used. This review did not have any extramural funding. Registration: PROSPERO record no. 42016043539. Results: We included 30 RCTs that were conducted on healthy or ill participants. Most of the trials reported beneficial effect of beta-glucan, but among the 105 different outcome domains and measures that were used, only three could be considered clinically relevant, while others were various biomarkers and surrogate outcomes such as complete blood count. Included studies on average had 33 participants per study arm, high or unclear risk of bias of at least one domain, and only half of them reported data for safety. More than half of trials that reported source of funding indicated commercial sponsorship from producers of beta-glucan. Only five RCTs reported trial registration. Conclusions: Commercial beta-glucan products were studied in a number of RCTs whose results can be considered only as preliminary, as they used small number of participants and surrogate outcomes. The quality of many studies was poor and further research and trials on bigger population should be performed before a final conclusion can be made.
... A couple of papers with yeast-derived β-glucans in the management of children with chronic respiratory problems were published by the group of Vetvicka & Richter [28][29][30][31][32][33]. In the similar cohorts of the children, they evaluated the effect of yeast-derived insoluble β-glucan on different salivary parameters and clinical characteristics. ...
... Concentration of cotinine (a marker of passive smoking exposure) and cortisol decreased in saliva after a 4-week-application of yeast β-glucan compared to placebo. Therefore authors suggested that β-glucan is able to reduce the negative environmental effects on children with chronic respiratory problems [31]. The possible preventive effect of β-glucan in children under physical stress was studied in another two trials of this authors' group. ...
Article
Full-text available
Respiratory tract infections (RTIs) are the most common form of infections in every age category. Recurrent respiratory tract infections (RRTIs), a specific form of RTIs, represent a typical and common problem associated with early childhood, causing high indirect and direct costs on the healthcare system. They are usually the consequence of immature immunity in children and high exposure to various respiratory pathogens. Their rational management should aim at excluding other severe chronic diseases associated with increased morbidity (e.g., primary immunodeficiency syndromes, cystic fibrosis, and ciliary dyskinesia) and at supporting maturity of the mucosal immune system. However, RRTIs can also be observed in adults (e.g., during exhausting and stressful periods, chronic inflammatory diseases, secondary immunodeficiencies, or in elite athletes) and require greater attention. Biologically active polysaccharides (e.g., β-glucans) are one of the most studied natural immunomodulators with a pluripotent mode of action and biological activity. According to many studies, they possess immunomodulatory, anti-inflammatory, and anti-infectious activities and therefore could be suggested as an effective part of treating and preventing RTIs. Based on published studies, the application of β-glucans was proven as a possible therapeutic and preventive approach in managing and preventing recurrent respiratory tract infections in children (especially β-glucans from Pleurotus ostreatus), adults (mostly the studies with yeast-derived β-glucans), and in elite athletes (studies with β-glucans from Pleurotus ostreatus or yeast).
... The effects of β-glucan on the immune system are summarized in Fig. 2A. Clinical trials into the effects of β-glucan on the immune system have now been conducted (55,56) and it has been demonstrated that β-glucans not only affect the immune system but may also reduce cholesterol levels. Different types of β-glucans, not only β-glucans found in oats, are able to reduce cholesterol levels. ...
Article
Full-text available
Hypercholesterolemia is one of primary risk factors of cardiovascular disease, together with metabolic syndrome, hypertension and diabetes. Although progress has been made, the search for novel methods of preventing and treating dyslipidemia is ongoing and current therapies for cardiovascular disease induce various side effects. β‑glucans are linear unbranched polysaccharides found in various natural sources, such as mushrooms. Due to their structure they are able to interact with innate immunity receptors, however they also act as dietary fibers in the digestive tract. As there are two forms of β‑glucans, insoluble and soluble forms, they are able to interact with lipids and biliary salts in the bowel and consequently reduce cholesterol levels. Therefore, they may be developed as a suitable therapeutic option to treat patients with dyslipidemia, as they are natural molecules that do not induce any significant side effects. The current review discusses the evidence supporting the effects of β‑glucans on cholesterol levels.
... A significant increase in the production of CRP, lysozyme, and calprotectin was observed in children supplemented with β-glucan. In another study, Richter et al. reported a strong reduction of salivary cortisol and cotinine levels in yeast β-glucansupplemented children [168]. A significant reduction in clinical problems of children affected with chronic respiratory disorders, and an increased physical endurance, was observed. ...
Article
Full-text available
β-Glucans are a group of biologically-active fibers or polysaccharides from natural sources with proven medical significance. β-Glucans are known to have antitumor, anti-inflammatory, anti-obesity, anti-allergic, anti-osteoporotic, and immunomodulating activities. β-Glucans are natural bioactive compounds and can be taken orally, as a food supplement, or as part of a daily diet, and are considered safe to use. The medical significance and efficiency of β-glucans are confirmed in vitro, as well as using animal- and human-based clinical studies. However, systematic study on the clinical and physiological significance of β-glucans is scarce. In this review, we not only discuss the clinical and physiological importance of β-glucans, we also compare their biological activities through the existing in vitro and animal-based in vivo studies. This review provides extensive data on the clinical study of β-glucans.
... We found significant improvements in production of secretory antibodies, improvement in the production of lysozyme, C-reactive protein and calprotectin. In addition, strong improvements in endurance were observed [8][9][10][11][12]. ...
Article
Full-text available
Article
Full-text available
Rationale: In vitro studies, animal experiments, and human exposure studies have shown how ambient air pollution increases the risk of atopic diseases. However, results derived from observational studies are inconsistent. Objectives: To assess the relationship between individual-based exposure to traffic-related air pollutants and allergic disease outcomes in a prospective birth cohort study during the first 6 years of life. Methods:We studied 2,860 children at the age of 4 years and 3,061 at the age of 6 years to investigate atopic diseases and allergic sensitization. Long-term exposure to particulate matter (PM2.5), PM2.5 absorbance, and long-term exposure to nitrogen dioxide (NO2) was assessed at residential addresses using geographic information systems based regression models and air pollution measurements. The distance to the nearest main road was used as a surrogate for traffic-related air pollutants. Measurements and Main Results: Strong positive associations were found between the distance to the nearest main road and asthmatic bronchitis, hay fever, eczema, and sensitization. A distance-dependent relationship could be identified, with the highest odds ratios (ORs) for children living less than 50 m from busy streets. For PM2.5 absorbance, statistically significant effects were found for asthmatic bronchitis (OR, 1.56; 95% confidence interval [CI], 1.03-2.37), hay fever (OR, 1.59; 95% CI, 1.11-2.27), and allergic sensitization to pollen (OR, 1.40; 95% CI, 1.20-1.64). NO2 exposure was associated with eczema, whereas no association was found for allergic sensitization. Conclusions: This study provides strong evidence for increased risk of atopic diseases and allergic sensitization when children are exposed to ambient particulate matter
Article
Full-text available
The role of glucan in stimulation of immune reactions has been well-established. In this report, we focused on the antibody production in glucan-supplemented children with chronic respiratory problems. We measured the levels of salivary IgA, IgM and IgG in 40 children aged 8-12 years and evaluated the effects of 100 mg d −1 oral dose of glucan. We found a significant increase in production of all tested antibodies in the glucan-stimulated group, but a decrease of antibody production in the control group. A thirty-day oral application of yeast-based natural immunomodulator β-glucan strongly stimulated the mucosal immunity of children with chronic respiratory problems.
Article
Full-text available
Background: The role of glucan in the stimulation of immune reactions is well established. In our report, we focused on the effects of orally administered glucan on nonspecific immunity of children with chronic respiratory problems. Materials and methods: We measured the levels of albumin, lysozyme. C-reactive protein (CRP) and calprotectin in the saliva of 60 children ages 8-12 years and evaluated the effects of 30-day treatment with 100 mg/d oral dose of glucan. Results: We found a significant increase in the production of lysozyme, CRP and calprotectin in glucan-treated children. Conclusions: Short-term oral application of natural immunomodulator β-glucan significantly stimulated mucosal immunity of children with chronic respiratory problems.
Article
Full-text available
Background: The role of glucan in stimulation of immune reactions has been studied for several decades. In this report we focused on the effects of orally administered glucan in children with chronic respiratory problems. Materials and methods: We measured the levels of albumin, lysozyme and CRP in saliva of 40 children aged 8-12 years and evaluate the effects of 100 mg/d oral dose of glucan. Results: We found a significant increase in production of changes in production of lysozyme and CRP in glucan-treated children. In addition, a strong improvement in general conditions was found. Conclusions: Short-term oral application of natural immunomodulator β-glucan stimulated mucosal immunity of children with chronic respiratory problems.
Article
Full-text available
The symptoms of atopic dermatitis (AD) are often aggravated by stress, and AD can also lead to psychological stress due to social isolation and discrimination. The salivary cortisol level reflects psychological stress, and it is a good index to assess chronic stress. In this study, we measured the salivary cortisol levels in patients with AD (n = 30) and compared them with those of healthy control subjects (n = 42). AD patients were also evaluated for general disease severity using the Scoring Atopic Dermatitis (SCORAD) index. The serum levels of TARC, total IgE, and lactate dehydrogenase (LDH) and peripheral blood eosinophil counts were measured by laboratory tests. The Skindex-16 was used as a skin disease-specific, quality of life measure, instrument. The results showed that the saliva cortisol level was significantly higher in AD patients compared to healthy subjects (P < 0.01). The salivary cortisol level was significantly correlated with the SCORAD index (r = 0.42, P < 0.05) while the serum TARC and LDH levels were positively correlated with the SCORAD index. However, no statistically significant correlations were observed between the salivary cortisol level and Skindex-16. These results suggest that the saliva cortisol level is therefore a useful biomarker to evaluate the stress in AD patients.
Article
Full-text available
Several studies have shown a baker's yeast beta-1,3/1,6-d-glucan, extracted from Saccharomyces cerevisiae, is effective in reducing the incidence of cold and flu symptoms. This study evaluated the effect of a specific beta-glucan supplement (Wellmune) on upper respiratory tract symptoms and psychological well-being in women with moderate levels of psychological stress. Healthy women (38 ± 12 years old) prescreened for moderate levels of psychological stress, self-administered a placebo (n = 38) or 250 mg of Wellmune (n = 39) daily for 12 weeks. We used the Profile of Mood States (POMS) psychological survey to assess changes in mental/physical energy levels (vigor) and overall well-being (global mood state). A quantitative health perception log was used to track upper respiratory symptoms. Subjects in the Wellmune group reported fewer upper respiratory symptoms compared to placebo (10% vs 29%), better overall well-being (global mood state: 99 ± 19 vs 108 ± 23, p < 0.05), and superior mental/physical energy levels (vigor: 19.9 ± 4.7 vs 15.8 ± 6.3, p < 0.05). These data show that daily dietary supplementation with Wellmune reduces upper respiratory symptoms and improves mood state in stressed subjects, and thus it may be a useful approach for maintaining immune protection against daily stressors.
Article
Full-text available
Secondhand smoke exposure (SHSe) is a known cause of many adverse health effects in adults and children. Increasingly, SHSe assessment is an element of tobacco control research and implementation worldwide. In spite of decades of development of approaches to assess SHSe, there are still unresolved methodological issues; therefore, a multidisciplinary expert meeting was held to catalogue the approaches to assess SHSe and with the goal of providing a set of uniform methods for future use by investigators and thereby facilitate comparisons of findings across studies. The meeting, held at Johns Hopkins, in Baltimore, Maryland, USA, was supported by the Flight Attendant Medical Research Institute (FAMRI). A series of articles were developed to summarise what is known about self-reported, environmental and biological SHSe measurements. Non-smokers inhale toxicants in SHS, which are mainly products of combustion of organic materials and are not specific to tobacco smoke exposure. Biomarkers specific to SHSe are nicotine and its metabolites (eg, cotinine), and metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). Cotinine is the preferred blood, saliva and urine biomarker for SHSe. Cotinine and nicotine can also be measured in hair and toenails. NNAL (4-[methylnitrosamino]-1-[3-pyridyl]-1-butanol), a metabolite of NNK, can be determined in the urine of SHS-exposed non-smokers. The selection of a particular biomarker of SHSe and the analytic biological medium depends on the scientific or public health question of interest, study design and setting, subjects, and funding. This manuscript summarises the scientific evidence on the use of biomarkers to measure SHSe, analytical methods, biological matrices and their interpretation.
Article
Oat β-glucan was purified from oat bran and its effects on running performance and related biochemical parameters were investigated. Four-week-old male Sparsgue-Dawley rats, fed with/without oat β-glucan (312.5mgkg(-1)d(-1)) for 7 weeks, were subjected to run on a treadmill system to make them exhausted. All rats were immediately sacrificed after prolonged exercise, and the major metabolic substrates were measured in serum and liver. The results showed feeding dietary oat β-glucan to rats could significantly reduce the body weight and increase the maximum running time compared with normal control (P<0.05). Furthermore, dietary oat β-glucan decreased the levels of blood urea nitrogen, lactate acid, and creatine kinase activity in serum, and increased the levels of non-esterified fatty acids, lactic dehydrogenase activity in serum, and the content of liver glycogen. Therefore, the present study demonstrated that dietary oat β-glucan can enhance the endurance capacity of rats while facilitating their recovery from fatigue.
Article
Pre- and postnatal stress have been related to allergy in children, but evidence from prospective studies is limited. Several environmental factors can influence the salivary cortisol level, which is used as a measure of activity of the hypothalamic-pituitary-adrenal axis. The aim of this study was to assess the association between salivary cortisol levels at 6 months of age and allergic manifestations during the first 2 years of life. Salivary samples for the analysis of cortisol level were collected at 6 months of age on 3 occasions during 1 day from 203 children. Blood samples were collected at 6, 12, and 24 months of age for analyses of specific IgE. Information on allergy-related symptoms was obtained by repeated examinations of the children. Generalized estimating equation statistics were used to calculate the overall risk for outcome measures. The adjusted odds ratio for the relationship between morning cortisol level and IgE sensitization was 1.60 (95% CI, 1.22-2.10, P = .001) and for eczema it was 1.28 (95% CI, 1.03-1.59, P = .026). The odds ratio for afternoon cortisol level in relation to sensitization and eczema was 1.56 (95% CI, 1.26-1.94, P < .001) and 1.33 (95% CI, 1.12-1.58, P = .001), respectively, and for evening cortisol level it was 1.49 (95% CI, 1.22-1.83, P < .001) and 1.37 (95% CI, 1.18-1.59, P < .001). Salivary cortisol level in the evening was associated with food allergy. The association between salivary cortisol levels in infancy and allergic sensitization and allergic symptoms suggests a role of an altered hypothalamic-pituitary-adrenal axis in the etiological process of allergies.